Deficiency of the cysteine protease cathepsin S impairs microvessel growth

被引:191
作者
Shi, GP
Sukhova, GK
Kuzuya, M
Ye, Q
Du, J
Zhang, Y
Pan, JH
Lu, ML
Cheng, XW
Iguchi, A
Perrey, S
Lee, AME
Chapman, HA
Libby, P
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[4] Nagoya Univ, Dept Geriatr, Nagoya, Aichi, Japan
关键词
angiogenesis; cathepsin S; wound healing; endothelial cells;
D O I
10.1161/01.RES.0000060485.20318.96
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During angiogenesis, microvascular endothelial cells (ECs) secrete proteinases that permit penetration of the vascular basement membrane as well as the interstitial extracellular matrix. This study tested the hypothesis that cathepsin S ( Cat S) contributes to angiogenesis. Treatment of cultured ECs with inflammatory cytokines or angiogenic factors stimulated the expression of Cat S, whereas inhibition of Cat S activity reduced microtubule formation by impairing cell invasion. ECs from Cat S-deficient mice showed reduced collagenolytic activity and impaired invasion of collagens type I and IV. Cat S-deficient mice displayed defective microvessel development during wound repair. This abnormal angiogenesis occurred despite normal vascular endothelial growth factor and basic fibroblast growth factor levels, implying an essential role for extracellular matrix degradation by Cat S during microvessel formation. These results demonstrate a novel function of endothelium-derived Cat S in angiogenesis.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 27 条
  • [1] AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
  • [2] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [3] The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
    Devy, L
    Blacher, S
    Grignet-Debrus, C
    Bajou, K
    Masson, R
    Gerard, RD
    Gils, A
    Carmeliet, G
    Carmeliet, P
    Declerck, PJ
    Noël, A
    Foidart, JM
    [J]. FASEB JOURNAL, 2002, 16 (02) : 147 - 154
  • [4] Secreted cathepsin L generates endostatin from collagen XVIII
    Felbor, U
    Dreier, L
    Bryant, RAR
    Ploegh, HL
    Olsen, BR
    Mothes, W
    [J]. EMBO JOURNAL, 2000, 19 (06) : 1187 - 1194
  • [5] Structural basis for different inhibitory specificities of human cystatins C and D
    Hall, A
    Ekiel, I
    Mason, RW
    Kasprzykowski, F
    Grubb, A
    Abrahamson, M
    [J]. BIOCHEMISTRY, 1998, 37 (12) : 4071 - 4079
  • [6] Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
    Haroon, ZA
    Hettasch, JM
    Lai, TS
    Dewhirst, MW
    Greenberg, CS
    [J]. FASEB JOURNAL, 1999, 13 (13) : 1787 - 1795
  • [7] Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    Heymans, S
    Luttun, A
    Nuyens, D
    Theilmeier, G
    Creemers, E
    Moons, L
    Dyspersin, GD
    Cleutjens, JPM
    Shipley, M
    Angellilo, A
    Levi, M
    Nübe, O
    Baker, A
    Keshet, E
    Lupu, F
    Herbert, JM
    Smits, JFM
    Shapiro, SD
    Baes, M
    Borgers, M
    Collen, D
    Daemen, MJAP
    Carmeliet, P
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1135 - 1142
  • [8] HOUCK KA, 1992, J BIOL CHEM, V267, P26031
  • [9] Matrix metalloproteinase and αvβ3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice
    Kanda, S
    Kuzuya, M
    Ramos, MA
    Koike, T
    Yoshino, K
    Ikeda, S
    Iguchi, A
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 998 - 1005
  • [10] Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
    Kos, J
    Sekirnik, A
    Kopitar, G
    Cimerman, N
    Kayser, K
    Stremmer, A
    Fiehn, W
    Werle, B
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1193 - 1200